TD Private Client Wealth LLC Sells 1,342 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

TD Private Client Wealth LLC reduced its stake in Option Care Health, Inc. (NASDAQ:OPCH) by 23.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,381 shares of the company’s stock after selling 1,342 shares during the period. TD Private Client Wealth LLC’s holdings in Option Care Health were worth $102,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Graypoint LLC purchased a new stake in Option Care Health during the 4th quarter worth about $1,161,000. Charles Schwab Investment Management Inc. boosted its position in shares of Option Care Health by 6.2% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,510,131 shares of the company’s stock valued at $58,235,000 after acquiring an additional 147,054 shares during the period. Global Alpha Capital Management Ltd. grew its stake in Option Care Health by 38.1% during the fourth quarter. Global Alpha Capital Management Ltd. now owns 68,810 shares of the company’s stock valued at $1,596,000 after acquiring an additional 18,992 shares in the last quarter. Y Intercept Hong Kong Ltd bought a new stake in Option Care Health during the 4th quarter worth approximately $327,000. Finally, Barclays PLC lifted its stake in Option Care Health by 180.1% in the 3rd quarter. Barclays PLC now owns 310,194 shares of the company’s stock worth $9,708,000 after purchasing an additional 199,454 shares in the last quarter. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Option Care Health Trading Up 1.4 %

OPCH stock opened at $35.18 on Wednesday. The company has a market capitalization of $5.78 billion, a PE ratio of 29.56, a price-to-earnings-growth ratio of 2.30 and a beta of 1.33. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. Option Care Health, Inc. has a one year low of $21.39 and a one year high of $35.44. The company’s 50 day moving average price is $32.11 and its two-hundred day moving average price is $28.33.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on OPCH. Bank of America upgraded shares of Option Care Health from a “neutral” rating to a “buy” rating and boosted their price target for the company from $26.00 to $33.00 in a research report on Monday, January 13th. JPMorgan Chase & Co. upped their target price on Option Care Health from $40.00 to $41.00 and gave the stock an “overweight” rating in a research note on Thursday, March 6th. Jefferies Financial Group upgraded Option Care Health from a “hold” rating to a “buy” rating and lifted their price target for the company from $26.00 to $35.00 in a research report on Thursday, January 23rd. UBS Group started coverage on shares of Option Care Health in a research report on Thursday, December 5th. They issued a “neutral” rating and a $26.00 price objective on the stock. Finally, Barrington Research lifted their target price on shares of Option Care Health from $33.00 to $38.00 and gave the company an “outperform” rating in a research report on Thursday, February 27th. Two equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $33.00.

Insider Buying and Selling

In other news, insider Michael Bavaro sold 30,996 shares of the firm’s stock in a transaction dated Friday, February 28th. The stock was sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the transaction, the insider now directly owns 44,974 shares of the company’s stock, valued at approximately $1,495,835.24. This trade represents a 40.80 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.64% of the stock is owned by corporate insiders.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.